You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 15, 2024

Litigation Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)

✉ Email this page to a colleague

« Back to Dashboard

Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)

Docket	⤷ Sign Up	Date Filed	2018-12-11
Court	District Court, D. Delaware	Date Terminated	2021-05-17
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Patents	10,039,745; 10,154,987; 6,211,244; 6,316,460; 8,568,747; 9,375,405; 9,669,008; 9,808,442
Link to Docket	External link to docket

Small Molecule Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Biologic Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.

The biologic drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2020-12-13			and Counterclaims with Respect to U.S. Patent Nos. 9,669,008 and 9,808,442 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2020-07-22	136	Notice of Service	Byrn on Infringement of U.S. Patent Nos. 9,669,008; 9,808,442; 10,039,745; and 10,154,987; and (2) Opening…John D. Mahan, Jr., M.D. on Infringement of U.S. Patent 9,808,442 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2020-10-19	145	Notice of Service	Stephen Byrn on the Infringement of U.S. Patents 10,039,745 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2020-10-30	147	Attachment 2	2 through 24 as obvious “over Van Wagenen (US 6,211,244 B1) as evidenced by Kajiyama et al. (US 6,656,492…two new patents. Amneal and Bionpharma were coordinated as to the first four Epaned patents for good… first set of Epaned patents to issue (the ’008, ’442, ’745, and ’987 patents). (C.A. No. 19-678 against…involves two patents that did not issue until September 2020 (the ’868 and ’482 patents), but that are…asserts the same six patents against both Amneal and Bionpharma. All six patents deal with the same technology	External link to document
2020-12-09	166	Stipulation of Dismissal	and Counterclaims with Respect to U.S. Patent Nos. 9,669,008 and 9,808,442 by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-10-31	22	Proposed Order	19-1067, which relates to asserted U.S. Patent No. 10,154,987, should also be included herein with the…and Judge Stark’s Revised Procedures for Managing Patent Cases (which is posted at 1 The parties…www.ded.uscourts.gov; see Chambers, Judge Leonard P. Stark, Patent Cases), and the parties having determined after…Identification of Accused Product(s) and Asserted Patent(s). By December… and the asserted patent(s) they alleged infringe, and produce the	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.